Search - tctmd.com

Displaying 101 - 120 of 121

Sort: Relevancy | Date

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Sodium Bicarbonate Is Still Relevant and Might Impact Mortality!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Impact of Contrast Nephropathy on Medical Management After PCI and on Early Outcomes

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Presenter: Mark C. Bates, Mark H. Wholey, Fabio Lima

October 13, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Carlo Briguori

September 16, 2014

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

Presentation TCT 2014

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Felix Mahfoud

September 14, 2014

Presentation TCT 2013

TCT-6. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry

Presenter: Usman Baber

October 29, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

Presentation TCT 2013

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Presenter: James Lai, M. Chadi Alraies, Wael Aljaroudi, Stephen Ellis, Leslie Cho

January 31, 2013

Presentation TCT 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presenter: Nicolas DUMONTEIL, Alaide Chieffo, Didier Tchetche, Nicolas Van Mieghem, Bertrand Marcheix, Robert M A Van Der Boon, Gill Buchanan, Olivier Vahdat, Patrick Serruys, Jean Fajadet, Peter De Jaegere, Antonio Colombo, Didier Carri?

January 31, 2013

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

Presentation TCT 2012

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

Advertisement

Convince Me in 5 Minutes or Less That: Sodium Bicarbonate Is Still Relevant and Might Impact Mortality!

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Impact of Contrast Nephropathy on Medical Management After PCI and on Early Outcomes

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

Asian TAVR Registry Shows Good Procedural and Clinical Results

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Clinical Trial Updates: RenalGuard, AVERT, etc.

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

Renal Denervation for Chronic Kidney Disease: Status and Case Example

TCT-6. Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry

Preliminary Data Show Potential of Renal Denervation in Several Settings

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

More Data Needed on Renal Denervation

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content